UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059379
Receipt number R000067912
Scientific Title Evaluation of the Usefulness of Continuous Positive Airway Pressure (CPAP) during EBUS-GS Guided Transbronchial Biopsy for Small Peripheral Pulmonary Lesions
Date of disclosure of the study information 2025/10/14
Last modified on 2025/10/12 16:09:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the Usefulness of Continuous Positive Airway Pressure (CPAP) during EBUS-GS Guided Transbronchial Biopsy for Pulmonary Lesions

Acronym

Usefulness of CPAP during Transbronchial Lung Biopsy

Scientific Title

Evaluation of the Usefulness of Continuous Positive Airway Pressure (CPAP) during EBUS-GS Guided Transbronchial Biopsy for Small Peripheral Pulmonary Lesions

Scientific Title:Acronym

CPAP in EBUS-GS Guided Biopsy for Small Peripheral Pulmonary Lesions

Region

Japan


Condition

Condition

Peripheral lung lesion

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Diagnostic yield of bronchoscopic biopsy under CPAP for peripheral pulmonary lesions.

Basic objectives2

Others

Basic objectives -Others

Diagnostic yield of bronchoscopic biopsy under CPAP for peripheral pulmonary lesions with a negative CT bronchus sign.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Diagnostic yield of bronchoscopic biopsy under CPAP for peripheral pulmonary lesions

Key secondary outcomes

Diagnostic yield of bronchoscopic biopsy under CPAP for peripheral pulmonary lesions with a negative CT bronchus sign.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

We are planning to use continuous positive airway pressure (CPAP) to keep the airways open during bronchoscopy, in order to improve lesion access and increase the diagnostic yield for small peripheral lung lesions.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who visit Fujita Health University Hospital and require a pathological diagnosis by bronchoscopy for a pulmonary nodule or opacity that meets all of the following criteria:
Patients who have received a full explanation about this study, fully understood the contents, and have provided written informed consent of their own free will.
Patients aged 20 years or older and younger than 90 years at the time of consent.
Patients with a target lesion less than or equal to 2 cm in the longest diameter on chest CT.
Patients who have undergone thin-slice chest CT (slice thickness less than 2 mm) prior to bronchoscopy.

Key exclusion criteria

Patients with an evident pneumothorax prior to the procedure.
Patients with respiratory failure (PaO2 less than 60 torr).
Patients whose systolic blood pressure is below 80 mmHg immediately before the start of bronchoscopy.
Any other patients judged to be inappropriate for inclusion by the principal investigator or sub-investigators.

Target sample size

85


Research contact person

Name of lead principal investigator

1st name Kazuyoshi
Middle name
Last name Imaizumi

Organization

Fujita Health University

Division name

Department of Respiratory Medicine

Zip code

4701192

Address

95 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, Japan

TEL

09065740609

Email

jeanluc@fujita-hu.ac.jp


Public contact

Name of contact person

1st name Kazuyoshi
Middle name
Last name Imaizumi

Organization

Fujita Health University

Division name

Department of Respiratory Medicine

Zip code

4560036

Address

95 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, Japan

TEL

09065740609

Homepage URL


Email

jeanluc@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health University

Institute

Department

Personal name

Kauzyosshi Imaizumi


Funding Source

Organization

Fujita Health University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Respiratory Medicine, Fujita Health University

Address

95 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, Japan

Tel

0562939241

Email

jeanluc@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

愛知


Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 10 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 03 Month 24 Day

Date of IRB

2024 Year 03 Month 26 Day

Anticipated trial start date

2024 Year 04 Month 01 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 10 Month 12 Day

Last modified on

2025 Year 10 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067912